The conolidine Diaries
These effects, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Issues.These results counsel that conolidin